Skip to main content
YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway
Published Web Location
http://europepmc.org/articles/PMC4408565?pdf=renderNo data is associated with this publication.
Abstract
© 2015 Chang et al.; licensee BioMed Central.Background: Novel-targeted therapies are in rapid development for the treatment of acute lymphoblastic leukemia (ALL) to overcome resistance and decrease toxicity. Survivin, a member of the inhibitor of apoptosi
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.